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Abstract:	
Multiple	mechanisms	in	the	HIV	lifecycle	play	a	role	in	its	ability	to	evade	therapy	and	become	a	chronic,	
difficult-to-treat	 infection.	 Within	 its	 major	 cellular	 target,	 the	 activated	 T	 cell,	 many	 steps	 occur	
between	viral	entry	and	viral	burst,	 including	reverse	transcription	of	viral	RNA,	integration	of	the	viral	
DNA	 in	 the	 host	 genome,	 viral	 transcription,	 splicing,	 translation,	 host	 and	 viral	 regulation,	 and	 viral	
packaging.	 These	 steps	 exploit	 complex	 networks	 of	macromolecular	 interactions	 that	 exhibit	 various	
forms	of	 stochastic	 behavior.	While	 each	 of	 the	 steps	 of	HIV	 infection	 have	 been	 individually	 studied	
extensively,	the	combinatorial	contribution	of	rare	events	in	each	of	the	steps,	and	how	series	of	these	
rare	 events	 lead	 to	 different	 infection	 phenotypes,	 are	 not	well	 understood.	 The	 complexity	 of	 these	
processes	 render	 experimental	 study	 challenging.	 Therefore,	 we	 have	 built	 a	 comprehensive	
computational	 model	 of	 this	 large	 system,	 by	 collating	 the	 community’s	 knowledge	 of	 the	 infection	
process.	 It	 is	 a	 stochastic	 model	 where	 rates	 of	 different	 events	 in	 the	 system	 are	 represented	 as	
probabilities	 of	 the	 event	 occurring	 in	 a	 timestep	 of	 the	 simulation.	 This	 model	 enables	 an	
understanding	 of	 the	 noise	 and	 variation	 in	 the	 system.	 The	 model	 also	 facilitates	 a	 dissected	
understanding	 of	 each	 small	 part	 of	 the	 large	 complex	 system,	 and	 its	 impact	 on	 the	 overall	 system	
dynamics.			
	
Introduction:	
Over	1.1	million	people	in	the	United	States	and	34.2	million	people	world-wide	are	living	with	Human	
Immunodeficiency	Virus	 (HIV).1	Given	the	gravity	and	transmissibility	of	this	disease,	HIV	has	been	the	
focus	of	research	in	many	labs	around	the	world.	The	efforts	to	understand	its	mechanism	of	infection,	
develop	 critically	 needed	 therapies,	 and	 eradicate	 the	 disease	 have	 culminated	 in	 a	 fairly	 large	
knowledgebase	 about	 this	 virus.	 However,	 molecularly,	 HIV’s	 infection	 process	 is	 very	 complex	 and	
involves	many	steps.	The	majority	of	research	done	on	this	field	involves	a	look	at	one	or	a	few	of	these	
steps.	 We	 have	 developed	 a	 tool	 to	 try	 to	 collate	 the	 community’s	 understanding	 of	 the	 molecular	
biology	 of	 HIV	 into	 one	 place	 to	 facilitate	 a	 systems	 level	 understanding	 of	 infection.	 This	 tool,	 a	
computational	 simulation	 of	 the	 molecular	 interaction	 between	 one	 HIV-1	 particle	 and	 one	 broadly	
defined	 T	 cell,	 includes	 every	 step	 of	 infection	 post	 DNA-integration.	 This	 comprehensive	 scope	 is	
necessary	because	none	of	the	steps	function	alone,	and	we	require	a	better	way	to	understand	how	the	
steps	 together	 impact	 infection	 dynamics.	 The	 model	 is	 particularly	 poised	 to	 look	 at	 the	 molecular	
variation	between	different	infection	events	and	its	impact	on	the	number	of	viable	progeny	generated	
by	a	single	HIV.		
The	motivation	behind	a	study	of	variation	stems	from	the	fact	that	the	most	common	HIV	treatments,	
such	as	highly	active	antiretroviral	 therapy	 (HAART),	are	only	able	 to	eliminate	 the	actively	 replicating	
HIV	population.	Low	levels	of	latent,	or	inactive,	virus	exist	in	patients’	cells,	and	if	a	patient	halts	HAART	
treatment,	 these	 latent	 populations	 may	 re-seed	 viral	 infection.2	 Patients	 must	 thus	 receive	 lifelong	
HAART	treatment,	resulting	in	issues	of	cost,	compliance,	drug	resistance,	side	effects,	and	susceptibility	
to	other	diseases.2	In	addition,	drug-resistant	variants	of	HIV	are	emerging	as	another	major	challenge	to	
current	 therapeutics.2	 Our	 comprehensive	 look	 at	 the	 system	 first	 offers	 the	 opportunity	 to	 discover	
new	 druggable	 targets	 to	 vary	 the	 points	 of	 intervention	 and	 address	 the	 issue	 of	 drug	 resistance.	
Second,	the	look	at	the	molecular	mechanisms	behind	variation	may	enable	the	ability	to	decrease	the	
variability	 in	the	system	to	1.	greatly	 increase	the	probability	of	generating	viable,	replicative,	progeny	
that	existing	treatments	can	eliminate	or	2.	greatly	decrease	the	probability	of	replicative	progeny	and	
slow	the	spread	of	infection.				
HAART	 and	 many	 existing	 treatments	 primarily	 target	 reverse	 transcriptase,	 the	 viral	 protein	 that	
converts	viral	RNA	into	DNA,	and	viral	integrase	that	integrates	viral	DNA	into	the	host’s	chromosomes.3	
To	focus	on	understanding	additional	targets,	this	simulation	starts	at	the	point	of	viral	DNA	integration	
and	 aims	 to	 explore	 the	 molecular	 variation	 at	 each	 step	 from	 integration	 to	 viral	 burst.	 This	 is	
accomplished	by	exploiting	the	apparent	modularity	of	biology,	and	assuming	that	biological	processes	
are	interconnected	at	long	time	scales	while	independent	at	shorter	time	scales.	Each	molecular	step	of	
the	 infection	 pathway	 is	 represented	 as	 an	 independent	 module	 in	 the	 simulation.	 The	 modules,	
including	mRNA	transcription,	Tat	(a	positive	regulator	of	viral	transcription)	feedback,	alternative	mRNA	
splicing,	 Rev	 (an	mRNA	 transport	 protein)	 binding	 to	mRNAs,	mRNA	export	 to	 the	 cytoplasm,	protein	
translation,	 mRNA	 an	 protein	 degradation,	 protein	 localization,	 Env	 (a	 viral	 envelope	 protein)	
processing,	and	viral	packaging	are	depicted	in	Figure	1.	The	modules	are	all	stochastic	representations	
of	 the	 underlying	 biology	 and	 incorporate	 a	 combination	 of	 novel	 representations	 and	
adaptations/modifications	of	existing	models.	Modularity	also	allows	the	swapping	out	of	sub-parts	and	
the	addition	of	more	detail,	as	this	project	progresses.	The	modules	are	all	 integrated	at	a	one	minute	
timestep,	 and	 the	 simulation	 runs	 for	 48	 hours	 of	 simulated	 time,	 the	 approximate	 lifetime	 of	 a	
productive	 HIV	 inside	 of	 a	 cell	 before	 it	 kills	 the	 cell.4	 The	 rate	 constants	 of	 critical	 steps	 in	 certain	
modules	are	much	shorter	than	a	minute,	and	in	these	cases	those	individual	modules	are	run	60	times	
per	“timestep”	to	simulate	variation	on	the	level	of	seconds.	The	model	explicitly	represents	each	virus	
derived	molecule	 in	 the	 system,	 but	 host	 proteins	 are	 assumed	 to	 be	 abundant.	 The	 stochasticity	 is	
achieved	 by	 representing	 individual	 rates	 of	 events	 as	 probabilities	 of	 the	 event	 occurring	 at	 a	 given	
timestep.	It	is	important	to	note	that	unlike	a	Gillespie	algorithm,	this	approach	only	randomizes	which	
events	will	occur	in	a	timestep	and	not	the	length	of	the	timestep	itself.	The	overall	methodology	used	
in	model	construction	is	very	similar	to	that	in	Karr	et	al.	2012.5			
Lastly,	 please	 note	 that	 the	 work	 presented	 here	 was	 completed	 in	 2014	 and	 no	 subsequent	
development	has	been	done.	This	submission	is	a	report	of	the	model	and	software	developed	at	that	
time	and	may	provide	a	useful	 starting	point	 for	others	 in	modeling	HIV	and	 its	underlying	processes.	
There	are	currently	no	plans	to	update	it	for	peer	review.	
	
Methods:	
A	 full	 description	 of	 the	model,	 framework,	 database	 of	 parameters,	 and	 references	 associated	 with	
each	 module	 can	 be	 found	 in	 the	 Supplementary	 Materials.	 All	 of	 the	 code	 may	 be	 found	 at	
https://github.com/donasaur/hiv-model.	Here,	we	will	summarize	the	biology	in	each	of	the	modules.		
	
First,	the	HIV	reverse	transcribed	DNA	integrates	into	the	host	chromosome	where	it	may	be	transcribed	
to	form	viral	mRNA.	In	the	transcription	module	we	first	consider	the	location	on	the	genome	that	the	
viral	 DNA	 integrated.	 We	 follow	 a	 simple	 model	 posed	 by	 Skupsky	 et	 al.,	 2010,	 in	 which	 the	 HIV	
promoter	 can	 be	 in	 an	 ON	 or	 OFF	 rate.6	 Skupsky	 et	 al.	 measured	 the	 gene	 expression	 levels,	
transcription	burst	size,	and	transcription	burst	 frequency	 in	30	clones	with	different	 integration	sites.	
They	 then	 computationally	 fit	 the	 values	 for	 the	 promoter	 on	 rate,	 promoter	 off	 rate,	 and	 basal	
transcription	rate	for	each	clone.	We	used	these	derived	values	for	the	constants	in	our	simulation.	We	
make	the	major	assumption	that	these	30	clones	represent	the	variation	of	these	parameters	across	all	
integration	sites	in	correct	proportion.	For	each	individual	simulation,	we	randomly	pick	a	number	1-30,	
and	that	simulation	will	run	using	the	Skupsky	et	al.	constants	for	the	corresponding	clone.	Upon	basal	
transcription,	 viral	 mRNAs	 begin	 to	 be	 produced.	 These	 “full	 length”	 mRNAs	 will	 be	 processed	 in	
subsequent	 modules	 to	 mRNAs	 encoding	 various	 proteins	 of	 the	 viral	 repertoire,	 and	 eventually	
generate	viral	proteins.	One	of	these	proteins,	Tat,	helps	enhance	the	rate	of	viral	transcription.	
In	the	Tat	feedback	module,	the	Tat	feedback	loop	is	modeled	after	the	one	described	in	Weinberger	et	
al,	2005.7	We	model	the	binding	of	Tat	to	host	factor	pTEFb,	pTEFb	acetylation,	and	its	effect	on	the	viral	
transcription	rate.	The	Tat	derived	transcription	rate	is	fed	into	the	Transcription	module.		
The	 alternative	 splicing	module,	 at	 certain	 probabilities,	 excises	 different	 parts	 of	 the	 full	 length	 viral	
mRNA.	Each	excision	 requires	host	machinery	 to	bind	at	a	donor	and	acceptor	 site,	which	excises	 the	
length	of	mRNA	between	these	two	sites.	The	splicing	model	 is	an	extension	of	that	presented	by	Kim	
and	Yin	in	2005.8	Up	to	3	splices	can	occur	per	mRNA	before	it	translocates	out	of	the	nucleus.	The	first	
splice	 event	 occurs	 between	 donor	 site	 1	 and	 one	 of	 7	 acceptor	 sites,	 leading	 to	 shortened	mRNAs	
encoding	Vif,	Vpr,	Tat,	Env,	Env,	Env,	and	Env.	 In	the	second	splice	event,	the	vif,	vpr,	and	env	mRNAs	
can	be	spliced	into	shortened	mRNAs	encoding	the	same	protein,	or	the	env	mRNAs	may	be	spliced	to	
rev	 or	 nef	 forms.	 In	 the	 third	 splice	 event,	 the	 doubly	 spiced	 vif	 or	 vpr	 mRNA	 can	 be	 additionally	
shortened	to	the	tat,	rev,	or	nef	forms.		
Only	the	transcripts	that	have	been	spliced	2	or	3	times	are	ready	for	transport	to	the	cytoplasm.	The	
single-spliced	and	full-length	mRNA	must	wait	for	Rev	molecules	to	bind	to	their	Rev	response	elements	
(this	 element	 has	 been	 excised	 from	 the	 multi-spliced	 RNAs,	 which	 is	 why	 Rev	 binding	 is	 not	 a	
requirement	for	them).	The	requirement	for	Rev	binding	essentially	poses	a	delay	on	certain	transcripts	
getting	 to	 the	cytoplasm.	The	Rev-independent	 transcripts	 start	 translation	before	 the	Rev-dependent	
transcripts.	 	 The	 Rev	 binding	module	 uses	 data	 from	 Pond	 et	 al.,	 2009	 to	 simulate	 the	 binding	 of	 8	
molecules	 of	 Rev	 to	 the	 Rev	 response	 element	 on	 single-spliced	 and	 full-length	mRNA.9	 Each	 binding	
event	has	its	own	probability	and	binding	depends	on	the	availability	of	Rev	and	competition	from	other	
mRNAs.	 Rev	 is	 also	 dissociable	 from	 this	 complex,	making	 complex	 formation	 a	 longer	 process.	Upon	
binding	8	Rev	molecules	(a	fittable	parameter),	the	mRNA	is	ready	for	transport	to	the	cytoplasm.			
The	 mRNA	 export	 module	 very	 simply	 moves	 multi-spliced	 mRNA	 and	 mRNA	 with	 8	 bound	 Rev	
molecules	into	the	cytoplasm	at	a	certain	probability.		
Once	 in	the	cytoplasm,	the	mRNA	may	be	translated	 into	proteins.	The	translation	module	transcribes	
mRNA	 into	proteins	 based	on	 a	 Poisson	distribution	of	 the	 frequency	of	 translation	multiplied	by	 the	
abundance	of	mRNA.	The	full	length	transcript	normally	encodes	the	Gag	molecule.	However,	there	is	a	
5%	 chance	 of	 a	 frameshift	 at	 the	 STOP	 site	 for	 Gag,	 such	 that	 the	 STOP	 is	 passed	 over	 and	 the	
Gag/Pro/Pol	 is	 translated.10	The	various	spliced	 forms	encode	different	proteins	as	described	above	 in	
the	description	of	 the	 alternative	 splicing	module.	 Translation	proceeds	 at	 its	maximal	 rate	 until	 high	
concentrations	of	Vpr	cause	a	G2/M	cell	cycle	arrest	and	the	suppression	of	normal	(5’	cap	dependent)	
translation.	 Even	 when	 the	 5’caps	 are	 blocked	 to	 ribosome	 entry	 on	 the	 HIV	mRNAs,	 the	 full-length	
mRNAs	have	a	 second	ribosome	entry	 site	 (Internal	 ribosome	entry	 site,	 IRES)	 in	 their	5’	untranslated	
region.	Therefore,	even	after	G2/M	cell	cycle	arrest,	Gag	and	Gag/Pro/Pol	can	still	be	produced	at	the	
frequency	 of	 IRES	 translation.11	 Once	 translated,	 the	 different	 proteins	 move	 from	 the	 cytoplasm	 to	
different	 compartments	 where	 they	 function.	 Rev	 and	 Tat	 act	 in	 the	 nucleus,	 Env	 moves	 into	 the	
endoplasmic	reticulum	(ER)	where	it	starts	to	be	glycosylated,	and	the	other	proteins	move	towards	the	
cell	membrane	for	packaging.		
The	protein	localization	module	takes	into	account	the	shuffling	of	Rev	and	Tat	between	the	nucleus	and	
the	cytoplasm.	Rev	and	Tat	are	synthesized	in	the	cytoplasm,	but	function	in	the	nucleus--Rev	to	aid	in	
mRNA	 export	 and	 Tat	 to	 increase	 the	 viral	 transcription	 rate.	 This	 process	 stochastically	 handles	 the	
shuffling	of	these	proteins	based	on	the	localization	rate	parameters.		
The	Env	processing	module	simulates	an	error-prone	multi-step	process	that	converts	nascent	Env	to	its	
functional	 form.	 Env	 (gp160)	 first	 moves	 to	 the	 ER	 where	 host	 cell	 oligosaccharytransferases	 and	
glucosidases	 start	 to	 glycosylate	 Env.12,13	 After	 the	 addition	 of	 some	 sugar	 chains,	 the	 chaperone	
Calnexin	 will	 start	 to	 fold	 Env	 such	 that	 additional	 host	 glucosidases	 can	 further	 modify	 Env’s	 sugar	
chains.14	At	this	point,	Env	is	transported	to	the	golgi,	where	host	mannosidases	and	sugar	transferases	
once	 again	modify	 Env’s	 sugar	 chains.	 All	 of	 these	 glycosylation	 steps	 are	 highly	 erroneous	 and	 it	 is	
thought	that	there	is	only	a	50%	chance	that	the	Env	molecule	is	successfully	glycosylated	at	this	point.15	
Both	 correctly	 and	 incorrectly	 glycosylated	 Env	molecules	 then	 trimerize,	 reducing	 the	 probability	 of	
obtaining	 trimers	with	 three	 correctly	 glycosylated	 Env	molecules.	 The	 trimers	 are	 then	 cleaved	 by	 a	
host	furin	protease	into	the	gp120	and	gp41	forms,	which	then	complex	back	with	each	other.16	Lastly,	
the	 Env	 trimers	 are	 translocated	 to	 the	 membrane	 where	 they	 can	 be	 incorporated	 into	 budding	
virons.17	Each	of	the	steps	in	this	Env	processing	module	is	stochastic	based	on	the	rate	of	the	step.			
Throughout	 the	 simulation,	 proteins	 and	mRNAs	 in	 any	 compartment	may	be	degraded	 stochastically	
based	on	their	decay	rates	in	the	Degradation	module.		
Lastly,	the	Packaging	module	simulates	the	movement	of	viral	and	host	proteins	to	the	cell	membrane	
and	the	formation	of	new	viral	particles.	Both	Vpr	and	Gag	levels	 in	a	cell	have	been	implicated	in	the	
switch	that	transitions	the	infected	cell	from	a	state	of	"translating"	to	a	state	of	"packaging."	Here,	we	
include	effects	of	both	signals.	First,	a	Vpr	threshold	is	reached	that	drives	the	cell	into	a	G2/M	arrest.18	
This	 signal	 is	 passed	 to	 the	 translation	module	 as	described	above.	Once	 in	G2/M	arrest,	 cytoplasmic	
monomeric	Gag	(not	membrane	bound)	can	start	to	bind	to	full	length	mRNAs	in	the	cytoplasm.	There	
are	four	stem-loops	(SL)	in	the	viral	RNA	that	Gag	can	bind	to	at	different	binding	constants.	Once	Gag	
has	bound	to	SL1,	SL2,	SL3,	the	RNA	has	a	conformational	change,	enabling	 it	 to	bind	to	another	Gag-
bound	RNA	 that	 also	has	 that	 conformational	 change.18	 The	whole	 "nucleated"	 complex	of	 two	RNAs	
and	 at	 least	 6	 Gag	molecules	 translocates	 to	 the	 cell	 membrane.	 Since	 the	 translocation	 time	 is	 not	
known,	 the	 model	 uses	 a	 rate	 roughly	 inferred	 by	 the	 diffusion	 time-scale.	 In	 the	 meantime,	 the	
remaining	 cytoplasmic	 Gag	may	 dimerize	 and/or	 migrate	 to	 the	 cell	 membrane.19	While	 trimers	 and	
larger	complexes	of	Gag	may	form,	monomers	and	dimers	are	most	prevalent,	and	are	the	only	forms	
included	in	this	model.19	All	of	the	above	steps	are	modeled	stochastically	based	on	rates	found	in	the	
literature	and	rates	derived	from	diffusion	approximations.		
Next,	the	Gag	molecules	(the	primary	structural	unit	of	an	HIV	particle)	start	to	assemble	into	budding	
virons.	There	is	a	lot	of	debate	on	the	number	of	Gag	per	HIV	particle,	and	we	used	an	average	of	2500	
Gag	molecules	per	viron.20	Assembly	is	initiated	at	the	site	of	a	“nucleated”	complex	at	the	membrane.	
The	Gag	monomers	and	dimers	may	move	from	the	cytoplasm	(slow)	or	the	membrane	(fast)	to	the	sites	
of	budding	virons.	We	are	modeling	exponentially	growing	budding	virons,	where	the	rate	of	growth	in	a	
given	 timestep	 is	dependent	on	 the	cytoplasmic	Gag	concentration,	and	 the	size	of	 the	budding	viron	
(cooperative	binding).	It	has	been	found	that	higher	Gag	concentrations	yield	faster	growing	virons,	and	
therefore	 in	 the	 model,	 the	 exponential	 rate	 constant	 is	 in	 part	 dependent	 on	 the	 cell’s	 Gag	
concentration	at	the	start	of	viron	growth.21		For	each	particle,	the	final	Gag	mass	is	determined	using	a	
Poisson	distribution	of	the	average	Gag	mass	(2500	molecules).	Particle	formation	is	complete	and	it	is	
ready	for	budding	when	this	Gag	mass	is	achieved.		In	the	meantime,	while	the	viron’s	Gag	structure	is	
being	formed,	other	HIV	and	host	proteins	assemble	with	 it.	The	rates	of	 incorporation	of	these	other	
proteins	 (Vif,	 Gag/Pro/Pol,	 Vpr,	 Nef)	 are	 based	 on	 the	 final	 ratios	 of	 these	 proteins	 to	 Gag	 in	 the	
viron.22,23,24	
	
All	of	the	parameters	used	 in	the	model	can	be	found	 in	the	parameters.csv	file	 included	with	the	full	
source	code.	Any	of	these	parameters	can	be	altered	via	sensitivity	analysis	to	understand	its	impact,	or	
altered	 permanently	 in	 the	 parameters.csv	 file	 as	 new	 information	 about	 HIV	 molecular	 biology	
becomes	available.		
	
	
Results	and	Discussion:	
Figure	2	displays	the	first	ten	hours	of	a	typical	simulation	and	depicts	the	following	expected	patterns.	
Growth	of	viral	mRNA	and	protein	is	very	slow	until	a	threshold	level	of	Tat	protein	is	produced,	at	which	
point	 the	 rate	 of	 transcription	 quickly	 increases	 (Figure	 2,	 grey	 dashed	 line).	 Transcripts	 are	made	 in	
their	full	 length	form	(encodes	Gag	or	Gag/Pol),	but	soon	may	be	spliced	into	forms	that	encode	other	
proteins.	While	it	takes	the	longest	to	generate	multi-spliced	mRNA,	this	is	the	first	form	to	translocate	
into	 the	 cytoplasm	 as	 it	 does	 not	 require	 the	 viral	 protein,	 Rev,	 for	 transport.	 Single-spliced	 and	 full	
length	mRNAs	must	wait	until	a	large	complex	of	Rev	molecules	bind	to	them,	before	we	see	their	entry	
in	the	cytoplasm.	The	Nef,	Rev,	Tat,	Vif,	and	Vpr	viral	proteins	all	have	a	multi-spliced	mRNA	form,	and	
therefore	are	the	first	proteins	that	are	synthesized.	Of	these,	Nef	is	produced	at	the	highest	abundance,	
and	Vif	and	Vpr	at	 the	 lowest.	As	Rev	 is	produced,	 the	full	and	single-spliced	mRNAs	compete	for	Rev	
and	 the	 eventual	 formation	 of	 an	 8-molecule	 Rev	 complex	 at	 their	 “Rev	 response	 element”	 site.	
Therefore,	 once	 the	 Rev	 levels	 in	 the	 cell	 are	 high	 enough	 that	 these	 complexes	 start	 to	 form,	 the	
remaining	mRNAs	may	 translocate	 into	 the	 cytoplasm	 and	 be	 translated	 (Figure	 2,	 grey	 dotted	 line).	
Once	 enough	 viral	 proteins	 are	 made,	 in	 particular	 Gag,	 the	 primary	 structural	 unit	 of	 a	 viron,	 viral	
progeny	start	to	be	made—only	a	fraction	of	which	are	actually	viable.	Our	proxy	for	defining	a	“viable”	
progeny	 is	 it	having	a	 threshold	 level	of	all	of	 its	essential	proteins.	 It	 is	 currently	defined	as	having	1	
viable	Env	molecule,15	at	 least	1.5%	of	 the	average	Vpr	per	viron,	and	10%	of	 the	average	 levels	of	all	
other	proteins	 in	the	viron.22,23,24	These	are	fittable	parameters	 in	the	model.	The	 low	requirement	for	
viable	 Env	 molecules	 stems	 from	 the	 very	 low	 successful	 Env	 glycosylation	 rate.25,26	 Overall,	 the	
simulation	allows	for	a	 look	at	mass	being	generated,	 lost,	and	moved	around	the	system	through	the	
context	of	various	different	processes	in	the	system.	It	enables	a	visual	understanding	of	different	delays	
and	dynamics	of	the	system.		
	
The	simulation	 is	built	 to	 facilitate	sensitivity	analysis	on	any	parameter	 in	 the	system.	We	performed	
sensitivity	 analysis	 on	 parameters	 from	 each	module	 in	 the	 system	 to	 understand	 how	 tuning	 those	
knobs	would	 impact	 the	virus’s	ability	 to	make	virons	and	noise	 in	 the	system.	Figure	3A-C	shows	 the	
total	 and	 viable	 progeny	 produced	 as	 we	 vary	 the	 basal	 transcription	 rate.	 Decreasing	 this	 rate	 will	
increase	 the	 time	 that	 it	 takes	 for	 Tat	 feedback	 of	 viral	 transcription	 to	 start	 and	 increasing	 this	 rate	
decrease	 the	 time	 till	 Tat	 feedback	 kicks	 in.	 Varying	 the	 rate	 10-fold	 in	 both	 directions	 shows	 that	
delaying	Tat	 feedback	has	a	big	 impact	on	the	eventual	production	of	viral	progeny	while	accelerating	
Tat	 feedback	 does	 not	 have	 a	 big	 effect.	 At	 higher	 basal	 transcription	 rates,	 the	 system	 may	 start	
transcribing	 faster,	 but	 other	 constraints	 in	 the	 system	 still	 control	 the	 progeny	 output.	 Figure	 3D-F	
shows	 the	 effect	 of	 tuning	 the	 promoter	ON	 rate.	 This	 parameter	 should	 have	 similar	 effects	 on	 the	
onset	of	Tat	feedback,	but	should	also	tune	the	noise	in	the	system.	We	find	that	the	promoter	ON	rate	
has	a	similar	effect	on	the	number	of	progeny	produced	 from	one	cell,	but	higher	promoter	ON	rates	
decrease	the	variation	in	total	progeny	counts.	The	variation	in	viable	progeny	counts	is	unaffected,	and	
probably	generated	by	processes	downstream	in	the	system.		
	
A	 second	example	of	 sensitivity	 analysis	 is	 depicted	 in	 Figure	 4	 and	 Supplemental	 Figure	 2	where	we	
vary	 the	 rates	 associated	 with	 alternative	 splicing.	 Each	 viral	 mRNA	 may	 be	 spliced	 in	 up	 to	 three	
locations,	and	each	splice	event	 is	controlled	by	 its	own	parameter.	The	different	splice	 forms	encode	
different	proteins.	Figure	4A-C	shows	the	effects	of	changing	the	probability	of	the	first	splice	event.	As	
the	probability	increases,	the	total	progeny	generated	decreases.	This	is	because	Gag,	a	product	of	the	
full	length	mRNA,	is	the	major	structural	unit	of	viral	progeny.	However,	generating	the	extra	Gag	comes	
at	 the	expense	of	 other	 viral	 proteins,	 and	 therefore	 the	 resulting	progeny	may	not	have	 a	 complete	
viral	protein	set,	and	therefore	be	inviable.	Therefore,	there	is	an	optimal	probability	of	the	first	splice	in	
a	 given	minute	 that	 generates	 the	maximum	number	 of	 viable	 progeny,	 estimated	 to	 be	 0.08	 in	 this	
simulation.	 The	 results	 of	 varying	 the	 probability	 of	 the	 second	 splice	 (Figure	 4D-F)	 show	 that	 there	
similarly	 is	an	optimal	probability	for	maximal	viable	progeny.	The	thirst	splice	takes	vif	and	vpr	mRNA	
and	splices	them	into	tat,	rev,	or	nef	mRNA.	Vif	and	Vpr	are	the	two	lowest	expressed	essential	proteins	
in	 a	 viron,	 and	 therefore,	 increasing	 the	 third	 splice	 form	 greatly	 decreases	 the	 viable	 progeny	 count	
(Supplemental	Figure	2).	These	patterns	start	to	hint	at	therapeutic	targets.	For	instance,	if	one	were	to	
reduce	the	ability	of	Rev	binding	to	viral	mRNAs	enough	that	mRNAs	stayed	in	the	nucleus	long	enough	
to	recieve	a	third	splice,	the	Vif	and	Vpr	concentration	in	a	cell	could	be	lowered	enough	to	significantly	
decrease	the	ability	to	generate	viable	viral	progeny.		
	
Supplemental	Figure	3	shows	results	of	sensitivity	analysis	on	parameters	 in	 the	other	modules	 in	our	
model.	This	illustrates	how	you	can	probe	each	part	of	the	system	to	understand	its	impact	on	progeny	
generation.	 For	 example,	 Supplemental	 Figure	 3I	 shows	 the	 effects	 of	 changing	 the	 average	 Gag	 per	
viron,	a	much	debated	parameter.	While	many	reports	measure	1250-2500	Gag	per	viron,	others	report	
5000	 or	 more	 Gag	 per	 viron.	 20,27,28	 Our	 results	 show	 that	 the	 optimal	 Gag	 content	 for	 progeny	
generation	 is	 1250-2500,	 and	 that	 the	 virus	 takes	 a	 huge	 hit	 on	 progeny	 production	 when	 the	 Gag	
content	per	virus	increases	beyond	this	point.		
	
Our	 simulation	 serves	 as	 a	 valuable	 tool	 for	 the	 HIV	 community.	 First,	 it	 enables	 a	 more	 complete	
understanding	of	the	molecular	mechanisms	of	HIV	and	a	visual	portrayal	of	system	dynamics.	Second,	it	
facilitates	probing	the	effect	of	each	variable	or	set	of	variables	on	the	system’s	dynamics	as	a	whole.	
Third,	 it	 explores	which	variables	 in	 the	 system	generate	a	 lot	or	 little	 variation	on	other	parts	of	 the	
system.	Lastly,	it	puts	all	of	the	system	dynamics	and	variation	in	the	context	of	viable	virus	production,	
to	 enable	 an	 understanding	 of	which	 factors	 in	 the	 system	 drive	 or	 suppress	 virality.	We	 present	 his	
model	 as	 a	 tool	 to	 help	 bring	 together	 various	 separate	 analyses	 of	 this	 system,	 and	 as	 more	
quantitative	measurements	are	made	on	the	system,	this	model	can	be	expanded	to	become	a	stronger	
and	 stronger	 predictor	 of	 the	 system’s	 outcomes.	 Further	 exploration	 using	 this	 tool	will	 continue	 to	
enhance	our	understanding	of	how	variation	propagates	through	the	HIV	infection	system,	and	how	one	
might	be	able	to	tune	variation	for	therapeutic	goals.		
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Figures:	
	
Figure	1:	 Schematic	of	 simulated	modules	and	 integration.	Depiction	of	 the	modules	 included	 in	 the	
model	and	when	each	becomes	active	over	time.	Arrows	indicate	the	passing	of	variables	between	the	
modules.		
	
	
	
	
	 	
Figure	2:	First	ten	hours	of	a	typical	simulation.	This	figure	shows	the	movement	of	mass	through	the	
HIV	 infection	 system	 including	 mRNA	 transcription,	 mRNA	 splicing,	 mRNA	 localization,	 protein	
translation,	and	the	formation	of	viral	progeny.		The	start	of	Tat	feedback	is	indicated	by	the	grey	dashed	
line,	and	the	start	of	Rev	binding	feedback	is	indicated	by	the	grey	dotted	line.		
	
	
	 	
Figure	 3:	 Sensitivity	 analysis	 of	 basal	 transcription	 rate	 and	 promoter	 ON	 rate.	 (A,B)	 The	 effect	 of	
tuning	the	basal	transcription	rate	on	total	and	viable	progeny	production.	Five	simulations	were	run	for	
each	 parameter	 value	 and	 the	 mean	 and	 individual	 runs	 are	 shown.	 (C)	 The	 mean	 and	 standard	
deviation	 of	 5	 simulations	 of	 progeny	 produced	 by	 the	 48th	 hour	 of	 simulation.	 	 (D-F)	 Similar	 plots	
varying	the	rate	of	turning	the	HIV	promoter	on.		
			
	
	 	
Figure	 4:	 Sensitivity	 analysis	 of	 alternative	 splicing	 probabilities.	 (A,B)	 The	 effect	 of	 tuning	 the	
probability	 of	 the	 first	 splice	 (from	 full-length	 to	 single-spliced	 mRNA)	 on	 total	 and	 viable	 progeny	
production.	Five	simulations	were	run	for	each	parameter	value	and	the	mean	and	 individual	runs	are	
shown.	(C)	The	mean	and	standard	deviation	of	5	simulations	of	progeny	produced	by	the	48th	hour	of	
simulation.		(D-F)	Similar	plots	varying	the	probability	of	the	second	splice	(single	to	multi-splice	mRNA).		
	
	 	
Supplemental	Figures:	
	
Supplemental	Figure	1:	Extension	of	Figure	2	to	show	an	entire	48	hour	simulation.		
	
	 	
Supplemental	Figure	2:	Sensitivity	analysis	of	the	third	alternative	splicing	probability.	(A,B)	The	effect	
of	tuning	the	probability	of	the	third	splice	(from	double-cut	to	triple	cut	multi-spliced	mRNA)	on	total	
and	viable	progeny	production.	Five	simulations	were	run	for	each	parameter	value	and	the	mean	and	
individual	runs	are	shown.	(C)	The	mean	and	standard	deviation	of	5	simulations	of	progeny	produced	
by	the	48th	hour	of	simulation.			
	
	 	
Supplemental	 Figure	 3:	 Sensitivity	 analysis	 on	 parameters	 from	 various	 modules.	 (A)	 Tuning	 the	
probability	of	an	Env	processing	error,	we	see	very	little	effect	on	progeny	output,	except	when	you	set	
the	error	 rate	to	100%.	This	 is	because	the	current	requirement	 is	set	 to	1	successfully	processed	Env	
molecule	per	viable	progeny.	 (B,C)	Tuning	the	rate	at	which	Rev	and	Tat	shuttle	back	 into	the	nucleus	
from	 the	 cytoplasm	 in	 the	 Protein	 Transport	 module	 does	 not	 have	 a	 large	 impact	 on	 progeny	
production.	 (D)	 The	 translation	 frequency	 as	 currently	 set	 in	 our	 model	 appears	 optimal	 for	 viable	
progeny	 generation.	 (E,F)	 The	 mRNA	 and	 protein	 degradation	 rates	 have	 a	 big	 impact	 on	 viral	
production,	with	the	mRNA	degradation	rate	having	a	much	larger	impact	as	it	has	a	higher	default	rate.	
We	tuned	the	nuclear	and	cytoplasmic	protein	degradation	rates	by	the	same	magnitude	in	each	tuning.	
(G)	Tuning	the	number	of	Rev	required	for	full	and	single-spliced	mRNA	to	translocate	to	the	cytoplasm.	
While	a	high	Rev	 requirement	 (default)	 generates	many	progeny,	 it	 is	 interesting	 to	note	 that	no	Rev	
requirement	actually	generates	 the	same	 if	not	more	progeny.	 (H)	The	Rev	binding	constant	does	not	
play	a	large	role	in	viral	productivity.	(I).	The	optimal	Gag	per	viron	is	2500	Gag	molecules	in	the	way	our	
model	is	currently	parameterized.		
	




		 	
Supplemental	Text:	
Please	see	the	docs	folder	of	the	project	code	located	at	https://github.com/donasaur/hiv-model.	The	
docs	folder	contains	the	following	documents:	
1. Overview	–	A	short	overview	of	the	simulator	and	a	listing	of	features	
2. Quick	start-up	guide	–	a	tutorial	on	software	required	to	run	the	model	and	how	to	download	
the	model	
3. User	Manual	
a. Introduction	
b. Plotting	guide	
c. Raw	data	output	tutorial	
d. Model	structure	
e. Testing	
f. Examples	
